Follow-up pre-seed equity round
27 MISK secured to validate in-vivo results
Akthelia has secured a closed follow-up bridge funding round. 12 existing shareholders, bought shares for a total of 27 mISK.
The plan for the investment is to conduct further animal studies, define target product profile and position the company to be institutional investor ready.